Last $16.95 USD
Change Today -0.08 / -0.47%
Volume 25.9K
OXFD On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 04/15/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michael D. Iseman M.D.

Senior Scientific Advisor, Oxford Immunotec Global PLC
AgeTotal Calculated CompensationThis person is connected to 18 board members in 2 different organizations across 3 different industries.

See Board Relationships
73--

Background*

Dr. Michael D. Iseman, MD has been a Senior Scientific Advisor of Oxford Immunotec Ltd. since June 2011. In this role, Dr. Iseman provides guidance to Oxford Immunotec and healthcare professionals in their efforts to improve the diagnosis of TB infection and eradicate tuberculosis in the United States. He serves as Chief of the Clinical Mycobacterial Disease Service at National Jewish Medical and Research Center. He has been a Professor of Medicine at the University ...

Read Full Background

Corporate Headquarters*

94C Innovation Drive
Abingdon, Oxfordshire OX14 4RZ

United Kingdom

Phone: 44 1235 442780
Fax: --

Board Members Memberships*

Director
2009-2013
Chairperson of Scientific Advisory Board

Education*

Bachelor's Degree 1961
Princeton University
MD 1965
Edward S. Harkness Eye Institute

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXFD:US $16.95 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peer M. Schatz Chairman of Management Board, Chief Executive Officer and Managing Director
Qiagen NV
$1.5M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OXFORD IMMUNOTEC GLOBAL PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.